Építés alatt – nem éles oldal
Belépés

623 open Méhnyakrák trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

OrszágOpen trials
Kína160
Olaszország40
Franciaország31
Spanyolország23
Dél-Korea22
All other countries

The same trial often runs in several countries

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22) has 32 sites in Egyesült Államok and runs in 29 countries. If a site near you is full, another one may still take people.

See A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22) in all 29 countries
Építés alatt, nem éles – Méhnyakrák: vizsgálatok itt: Egyesült Államok – Frontlight Research